Forms and Documents
The Prescriber Service Form is filled out by the health care provider and is used to collect the patient’s health insurance and treatment information.
Patient Consent Form
The Patient Consent Form is filled out by the patient and gives permission for Genentech to work with the health care provider and the patient’s health insurance plan.
Spanish Patient Consent Form (Formulario de Consentimiento del Paciente)
A version of the Patient Consent Form for your Spanish-speaking patients.
Download Selected 0 files selected Files will be downloaded as .zip file.
- Complete and submit a form electronically.
Other Important Documents
Enrolling in the Genentech Patient Foundation
The Genentech Patient Foundation gives free Genentech medicine to people who don't have health insurance coverage or who have financial concerns and meet eligibility criteria. Two forms are needed to enroll in the Genentech Patient Foundation:
- Prescriber Foundation Form (to be completed by the health care provider).
- Patient Consent Form (to be completed by the patient).
Considerations for Composing a Letter of Medical Necessity
This guide provides tips to help you draft a letter of medical necessity. A sample letter is also included for your reference. Use the links below to find additional information to enclose in your letter.
FDA approval letter (Follow this link and search by the drug name)
Considerations for Composing a Sample Appeal Letter
This guide provides tips to help you draft an appeal letter. A sample letter is also included for your reference. Use the links below to find additional information to enclose in your letter.
FDA approval letter (Follow this link and search by the drug name)
Recertification Reminder Program Enrollment Form
Use this form to enroll your practice in the XOLAIR Recertification Reminder Program for patient prior authorization reminder notifications.
Fax Cover Letter
Use this cover sheet when faxing documents to XOLAIR Access Solutions.
For assistance, call (877) GENENTECH/(877) 436-3683
6 a.m.–5 p.m. PT, Monday through Friday
© 2024 Genentech USA, Inc. All rights reserved. This site is intended for U.S. residents only.
Please select medication to continue
- ACTEMRA® (tocilizumab)
- ALECENSA® (alectinib)
- Avastin ® (bevacizumab)
- COLUMVI ™ (glofitamab-gxbm)
- COTELLIC ® (cobimetinib)
- ENSPRYNG ® (satralizumab-mwge)
- Erivedge ® (vismodegib)
- Evrysdi ® (risdiplam)
- GAZYVA ® (obinutuzumab)
- HEMLIBRA ® (emicizumab-kxwh)
- Herceptin ® (trastuzumab)
- Herceptin HYLECTA ™ (trastuzumab and hyaluronidase-oysk)
- KADCYLA ® (ado-trastuzumab emtansine)
- LUCENTIS ® (ranibizumab injection)
- LUNSUMIO™ (mosunetuzumab-axgb)
- OCREVUS ® (ocrelizumab)
- PERJETA ® (pertuzumab)
- PHESGO ™ (pertuzumab, trastuzumab, and hyaluronidase-zzxf)
- PiaSky ™ (crovalimab-akkz)
- POLIVY ® (polatuzumab vedotin-piiq)
- Pulmozyme ® (dornase alfa) Inhalation Solution
- Rituxan ® (rituximab) for Rheumatoid Arthritis (RA)
- RITUXAN ® (rituximab) for Oncology
- Rituxan ® (rituximab) for Granulomatosis with Polyangiitis (GPA), Microscopic Polyangiitis (MPA) or Pemphigus Vulgaris (PV)
- RITUXAN HYCELA ® (rituximab/hyaluronidase human)
- ROZLYTREK ® (entrectinib)
- SUSVIMO ™ (ranibizumab injection)
- TECENTRIQ ® (atezolizumab)
- VABYSMO ® (faricimab-svoa)
- VENCLEXTA ® (venetoclax tablets)
- XOLAIR ® (omalizumab) for subcutaneous use
- ZELBORAF ® (vemurafenib)
OR SELECT
Please select medication to continue
- ACTEMRA ® (tocilizumab)
- ALECENSA ® (alectinib)
- Avastin ® (bevacizumab)
- COLUMVI ™ (glofitamab-gxbm)
- COTELLIC ® (cobimetinib)
- ENSPRYNG ® (satralizumab-mwge)
- Erivedge ® (vismodegib)
- Evrysdi ® (risdiplam)
- GAZYVA ® (obinutuzumab)
- HEMLIBRA ® (emicizumab-kxwh)
- Herceptin ® (trastuzumab)
- Herceptin HYLECTA ™ (trastuzumab and hyaluronidase-oysk)
- KADCYLA ® (ado-trastuzumab emtansine)
- LUCENTIS ® (ranibizumab injection)
- LUNSUMIO™ (mosunetuzumab-axgb)
- OCREVUS ® (ocrelizumab)
- PERJETA ® (pertuzumab)
- PHESGO ™ (pertuzumab, trastuzumab, and hyaluronidase-zzxf)
- PiaSky ™ (crovalimab-akkz)
- POLIVY ® (polatuzumab vedotin-piiq)
- Pulmozyme ® (dornase alfa) Inhalation Solution
- Rituxan ® (rituximab) for Rheumatoid Arthritis (RA)
- RITUXAN ® (rituximab) for Oncology
- Rituxan ® (rituximab) for Granulomatosis with Polyangiitis (GPA), Microscopic Polyangiitis (MPA) or Pemphigus Vulgaris (PV)
- RITUXAN HYCELA ® (rituximab/hyaluronidase human)
- ROZLYTREK ® (entrectinib)
- SUSVIMO ™ (ranibizumab injection)
- TECENTRIQ ® (atezolizumab)
- VABYSMO ® (faricimab-svoa)
- VENCLEXTA ® (venetoclax tablets)
- XOLAIR ® (omalizumab) for subcutaneous use
- ZELBORAF ® (vemurafenib)
OR SELECT
Please select medication to continue
- ACTEMRA ® (tocilizumab)
- ALECENSA ® (alectinib)
- Avastin ® (bevacizumab)
- COLUMVI ™ (glofitamab-gxbm)
- COTELLIC ® (cobimetinib)
- ENSPRYNG ® (satralizumab-mwge)
- Erivedge ® (vismodegib)
- Evrysdi ® (risdiplam)
- GAZYVA ® (obinutuzumab)
- HEMLIBRA ® (emicizumab-kxwh)
- Herceptin ® (trastuzumab)
- Herceptin HYLECTA ™ (trastuzumab and hyaluronidase-oysk)
- KADCYLA ® (ado-trastuzumab emtansine)
- LUCENTIS ® (ranibizumab injection)
- LUNSUMIO™ (mosunetuzumab-axgb)
- OCREVUS ® (ocrelizumab)
- PERJETA ® (pertuzumab)
- PHESGO ™ (pertuzumab, trastuzumab, and hyaluronidase-zzxf)
- PiaSky ™ (crovalimab-akkz)
- POLIVY ® (polatuzumab vedotin-piiq)
- Pulmozyme ® (dornase alfa) Inhalation Solution
- Rituxan ® (rituximab) for Rheumatoid Arthritis (RA)
- RITUXAN ® (rituximab) for Oncology
- Rituxan ® (rituximab) for Granulomatosis with Polyangiitis (GPA), Microscopic Polyangiitis (MPA) or Pemphigus Vulgaris (PV)
- RITUXAN HYCELA ® (rituximab/hyaluronidase human)
- ROZLYTREK ® (entrectinib)
- SUSVIMO™ (ranibizumab injection)
- TECENTRIQ ® (atezolizumab)
- VABYSMO ® (faricimab-svoa)
- VENCLEXTA ® (venetoclax tablets)
- XOLAIR ® (omalizumab) for subcutaneous use
- ZELBORAF ® (vemurafenib)
OR SELECT
Please select medication to continue
- ACTEMRA ® (tocilizumab)
- ALECENSA ® (alectinib)
- Avastin ® (bevacizumab)
- COLUMVI ™ (glofitamab-gxbm)
- COTELLIC ® (cobimetinib)
- ENSPRYNG ® (satralizumab-mwge)
- Erivedge ® (vismodegib)
- Evrysdi ® (risdiplam)
- GAZYVA ® (obinutuzumab)
- HEMLIBRA ® (emicizumab-kxwh)
- Herceptin ® (trastuzumab)
- Herceptin HYLECTA ™ (trastuzumab and hyaluronidase-oysk)
- KADCYLA ® (ado-trastuzumab emtansine)
- LUCENTIS ® (ranibizumab injection)
- LUNSUMIO™ (mosunetuzumab-axgb)
- OCREVUS ® (ocrelizumab)
- PERJETA ® (pertuzumab)
- PHESGO ™ (pertuzumab, trastuzumab, and hyaluronidase-zzxf)
- PiaSky ™ (crovalimab-akkz)
- POLIVY ® (polatuzumab vedotin-piiq)
- Pulmozyme ® (dornase alfa) Inhalation Solution
- Rituxan ® (rituximab) for Rheumatoid Arthritis (RA)
- RITUXAN ® (rituximab) for Oncology
- Rituxan ® (rituximab) for Granulomatosis with Polyangiitis (GPA), Microscopic Polyangiitis (MPA) or Pemphigus Vulgaris (PV)
- RITUXAN HYCELA ® (rituximab/hyaluronidase human)
- ROZLYTREK ® (entrectinib)
- SUSVIMO™ (ranibizumab injection)
- TECENTRIQ ® (atezolizumab)
- VABYSMO ® (faricimab-svoa)
- VENCLEXTA ® (venetoclax tablets)
- XOLAIR ® (omalizumab) for subcutaneous use
- ZELBORAF ® (vemurafenib)
OR SELECT
Please select medication to continue
- ACTEMRA ® (tocilizumab)
- ALECENSA ® (alectinib)
- Avastin ® (bevacizumab)
- COLUMVI ™ (glofitamab-gxbm)
- COTELLIC ® (cobimetinib)
- ENSPRYNG ® (satralizumab-mwge)
- Erivedge ® (vismodegib)
- Evrysdi ® (risdiplam)
- GAZYVA ® (obinutuzumab)
- HEMLIBRA ® (emicizumab-kxwh)
- Herceptin ® (trastuzumab)
- Herceptin HYLECTA ™ (trastuzumab and hyaluronidase-oysk)
- KADCYLA ® (ado-trastuzumab emtansine)
- LUCENTIS ® (ranibizumab injection)
- LUNSUMIO™ (mosunetuzumab-axgb)
- OCREVUS ® (ocrelizumab)
- PERJETA ® (pertuzumab)
- PHESGO ™ (pertuzumab, trastuzumab, and hyaluronidase-zzxf)
- PiaSky ™ (crovalimab-akkz)
- POLIVY ® (polatuzumab vedotin-piiq)
- Pulmozyme ® (dornase alfa) Inhalation Solution
- Rituxan ® (rituximab) for Rheumatoid Arthritis (RA)
- RITUXAN ® (rituximab) for Oncology
- Rituxan ® (rituximab) for Granulomatosis with Polyangiitis (GPA), Microscopic Polyangiitis (MPA) or Pemphigus Vulgaris (PV)
- RITUXAN HYCELA ® (rituximab/hyaluronidase human)
- ROZLYTREK ® (entrectinib)
- SUSVIMO ™ (ranibizumab injection)
- TECENTRIQ ® (atezolizumab)
- VABYSMO ® (faricimab-svoa)
- VENCLEXTA ® (venetoclax tablets)
- XOLAIR ® (omalizumab) for subcutaneous use
- ZELBORAF ® (vemurafenib)
OR SELECT
Please select medication to continue
- ACTEMRA ® (tocilizumab)
- ALECENSA ® (alectinib)
- Avastin ® (bevacizumab)
- COLUMVI ™ (glofitamab-gxbm)
- COTELLIC ® (cobimetinib)
- ENSPRYNG ® (satralizumab-mwge)
- Erivedge ® (vismodegib)
- Evrysdi ® (risdiplam)
- GAZYVA ® (obinutuzumab)
- HEMLIBRA ® (emicizumab-kxwh)
- Herceptin ® (trastuzumab)
- Herceptin HYLECTA ™ (trastuzumab and hyaluronidase-oysk)
- KADCYLA ® (ado-trastuzumab emtansine)
- LUCENTIS ® (ranibizumab injection)
- LUNSUMIO™ (mosunetuzumab-axgb)
- OCREVUS ® (ocrelizumab)
- PERJETA ® (pertuzumab)
- PHESGO ™ (pertuzumab, trastuzumab, and hyaluronidase-zzxf)
- PiaSky ™ (crovalimab-akkz)
- POLIVY ® (polatuzumab vedotin-piiq)
- Pulmozyme ® (dornase alfa) Inhalation Solution
- Rituxan ® (rituximab) for Rheumatoid Arthritis (RA)
- RITUXAN ® (rituximab) for Oncology
- Rituxan ® (rituximab) for Granulomatosis with Polyangiitis (GPA), Microscopic Polyangiitis (MPA) or Pemphigus Vulgaris (PV)
- RITUXAN HYCELA ® (rituximab/hyaluronidase human)
- ROZLYTREK ® (entrectinib)
- SUSVIMO ™ (ranibizumab injection)
- TECENTRIQ ® (atezolizumab)
- VABYSMO ® (faricimab-svoa)
- VENCLEXTA ® (venetoclax tablets)
- XOLAIR ® (omalizumab) for subcutaneous use
- ZELBORAF ® (vemurafenib)
OR SELECT
Please select medication to continue
- ACTEMRA ® (tocilizumab)
- ALECENSA ® (alectinib)
- Avastin ® (bevacizumab)
- COLUMVI ™ (glofitamab-gxbm)
- COTELLIC ® (cobimetinib)
- ENSPRYNG ® (satralizumab-mwge)
- Erivedge ® (vismodegib)
- Evrysdi ® (risdiplam)
- GAZYVA ® (obinutuzumab)
- HEMLIBRA ® (emicizumab-kxwh)
- Herceptin ® (trastuzumab)
- Herceptin HYLECTA ™ (trastuzumab and hyaluronidase-oysk)
- KADCYLA ® (ado-trastuzumab emtansine)
- LUCENTIS ® (ranibizumab injection)
- LUNSUMIO™ (mosunetuzumab-axgb)
- OCREVUS ® (ocrelizumab)
- PERJETA ® (pertuzumab)
- PHESGO ™ (pertuzumab, trastuzumab, and hyaluronidase-zzxf)
- PiaSky ™ (crovalimab-akkz)
- POLIVY ® (polatuzumab vedotin-piiq)
- Pulmozyme ® (dornase alfa) Inhalation Solution
- Rituxan ® (rituximab) for Rheumatoid Arthritis (RA)
- RITUXAN ® (rituximab) for Oncology
- Rituxan ® (rituximab) for Granulomatosis with Polyangiitis (GPA), Microscopic Polyangiitis (MPA) or Pemphigus Vulgaris (PV)
- RITUXAN HYCELA ® (rituximab/hyaluronidase human)
- ROZLYTREK ® (entrectinib)
- SUSVIMO ™ (ranibizumab injection)
- TECENTRIQ ® (atezolizumab)
- VABYSMO ® (faricimab-svoa)
- VENCLEXTA ® (venetoclax tablets)
- XOLAIR ® (omalizumab) for subcutaneous use
- ZELBORAF ® (vemurafenib)
OR SELECT
Please select medication to continue
- ACTEMRA ® (tocilizumab)
- ALECENSA ® (alectinib)
- Avastin ® (bevacizumab)
- COLUMVI ™ (glofitamab-gxbm)
- COTELLIC ® (cobimetinib)
- ENSPRYNG ® (satralizumab-mwge)
- Erivedge ® (vismodegib)
- Evrysdi ® (risdiplam)
- GAZYVA ® (obinutuzumab)
- HEMLIBRA ® (emicizumab-kxwh)
- Herceptin ® (trastuzumab)
- Herceptin HYLECTA ™ (trastuzumab and hyaluronidase-oysk)
- KADCYLA ® (ado-trastuzumab emtansine)
- LUCENTIS ® (ranibizumab injection)
- LUNSUMIO™ (mosunetuzumab-axgb)
- OCREVUS ® (ocrelizumab)
- PERJETA ® (pertuzumab)
- PHESGO ™ (pertuzumab, trastuzumab, and hyaluronidase-zzxf)
- PiaSky ™ (crovalimab-akkz)
- POLIVY ® (polatuzumab vedotin-piiq)
- Pulmozyme ® (dornase alfa) Inhalation Solution
- Rituxan ® (rituximab) for Rheumatoid Arthritis (RA)
- RITUXAN ® (rituximab) for Oncology
- Rituxan ® (rituximab) for Granulomatosis with Polyangiitis (GPA), Microscopic Polyangiitis (MPA) or Pemphigus Vulgaris (PV)
- RITUXAN HYCELA ® (rituximab/hyaluronidase human)
- ROZLYTREK ® (entrectinib)
- SUSVIMO ™ (ranibizumab injection)
- TECENTRIQ ® (atezolizumab)
- VABYSMO ® (faricimab-svoa)
- VENCLEXTA ® (venetoclax tablets)
- XOLAIR ® (omalizumab) for subcutaneous use
- ZELBORAF ® (vemurafenib)
OR SELECT
Link to Healthcare Professionals Site
The information contained in this section of the site is intended for U.S. healthcare professionals only. Click "OK" if you are a healthcare professional.
Link to Third Party Site
The link you have selected will take you away from this site to one that is not owned or controlled by Genentech, Inc. Genentech, Inc. makes no representation as to the accuracy of the information contained on sites we do not own or control. Genentech does not recommend and does not endorse the content on any third-party websites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.